GRAIL, Inc. $GRAL Stock Holdings Increased by Ameriflex Group Inc.

Ameriflex Group Inc. raised its holdings in shares of GRAIL, Inc. (NASDAQ:GRAL) by 19.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,655 shares of the company’s stock after acquiring an additional 3,400 shares during the period. Ameriflex Group Inc. owned approximately 0.06% of GRAIL worth $1,020,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Caldwell Sutter Capital Inc. bought a new stake in GRAIL during the 1st quarter valued at $28,000. KBC Group NV raised its stake in GRAIL by 187.7% during the 1st quarter. KBC Group NV now owns 1,430 shares of the company’s stock valued at $37,000 after acquiring an additional 933 shares in the last quarter. S.A. Mason LLC raised its stake in GRAIL by 50.1% during the 1st quarter. S.A. Mason LLC now owns 1,499 shares of the company’s stock valued at $38,000 after acquiring an additional 500 shares in the last quarter. Farther Finance Advisors LLC raised its stake in GRAIL by 768.1% during the 2nd quarter. Farther Finance Advisors LLC now owns 816 shares of the company’s stock valued at $42,000 after acquiring an additional 722 shares in the last quarter. Finally, NewEdge Advisors LLC raised its stake in GRAIL by 390.3% during the 1st quarter. NewEdge Advisors LLC now owns 1,760 shares of the company’s stock valued at $45,000 after acquiring an additional 1,401 shares in the last quarter.

Insiders Place Their Bets

In related news, CFO Aaron Freidin sold 8,000 shares of GRAIL stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total value of $311,440.00. Following the transaction, the chief financial officer directly owned 286,020 shares in the company, valued at $11,134,758.60. The trade was a 2.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Joshua J. Ofman sold 9,692 shares of GRAIL stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $64.00, for a total value of $620,288.00. Following the completion of the transaction, the president owned 478,182 shares in the company, valued at $30,603,648. The trade was a 1.99% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 21,894 shares of company stock worth $1,066,276 over the last 90 days. Insiders own 1.85% of the company’s stock.

GRAIL Stock Up 1.3%

Shares of NASDAQ GRAL opened at $65.54 on Friday. The stock has a market capitalization of $2.36 billion, a price-to-earnings ratio of -5.00 and a beta of 4.11. The stock’s fifty day simple moving average is $38.69 and its 200 day simple moving average is $37.12. GRAIL, Inc. has a 52-week low of $12.33 and a 52-week high of $73.74.

GRAIL (NASDAQ:GRAL) last issued its earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.14) by ($0.04). The company had revenue of $35.54 million during the quarter, compared to analyst estimates of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. As a group, analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on GRAL shares. UBS Group set a $75.00 price target on GRAIL in a research report on Friday. Canaccord Genuity Group lifted their price target on GRAIL from $43.00 to $75.00 and gave the company a “buy” rating in a research report on Friday. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of GRAIL in a research report on Saturday, September 27th. One equities research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $56.67.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.